Solid Team:Founders

Solid is the English translation of Eytani, the Hebrew name of Ilan and Annie Ganot’s son, who was diagnosed with Duchenne muscular dystrophy (Duchenne) in 2012.

Following this diagnosis, Ilan and Annie co-founded Solid Biosciences in 2013 with our Chairman of the Board, Andrey Zarur, as well as Matt Arnold and Gilad Hayeem. Unsatisfied with the existing Duchenne treatment landscape, they built a disease-focused company with the team, infrastructure and potential to advance innovative science quickly and responsibly.